Muscle wasting occurs in patients with cancer, muscular dystrophy, COPD, chronic kidney disease, nerve damage or heart failure. It also occurs with aging and in each situation, can have fatal consequences. AVGN7 is a viral gene therapeutic that blocks the inhibitory actions of myostatin, GDF11 and activin. In animal studies, its specificity for muscle and heart prevents their wasting without the dangerous side effects that have limited competing technologies.
EpigeneSys will exploit proprietary technology and initially use contract service providers and collaborators with known clinical cohorts to identify disease associated epigenetic biomarkers and epigenetic signatures. Subsequently, the Company will develop diagnostic products/services using more appropriate [lower cost] targeted technology and these diagnostics will be provided as a clinical service in a CLIA lab. The Company is seeking investors and partners to execute the commercialization strategy.
Athira Pharma is a drug development company striving to improve human health by advancing new therapies for neurodegenerative diseases like Alzheimer’s and Parkinson’s. Our innovative approach is focused on turning brain degeneration into regeneration by re-establishing lost connections and restoring lost function.
DL ADV-Tech LLC
DL ADV Tech is establishing a novel real-time and rapid system that can be used universally to quantify a wide variety of biomarkers in the fields of medical diagnostics, food safety, public health, and environmental monitoring. With this method, any molecule which can be attached to an antibody can be tested in the field or office without the use of expensive or complicated laboratory equipment.
The pursuiting a propitory digonositcs to detect trichomonas vaginalis more accurate and specific and less invasive than existing methods.
- Email us
Rewire Neuroscience is dedicated to empowering the future of neuroscience. Our goal is to help early stage scientists get ahead in a competitive research landscape. We develop products that are well built, affordable, and designed by neuroscientists who use the product.
Cancer Targeted Technology
CTT is a biotechnology company commercializing innovative small molecules that bind pivotal enzyme targets in cancer. CTT has rationally designed and patented a targeting scaffold that recognizes the molecular target, Prostate-Specific Membrane Antigen (PSMA), with unparalleled binding characteristics, making it stand out from its competitors. PSMA is an exceptional biomarker, expressed on close to 90% of prostate tumors, with increased PSMA expression correlated with disease progression while normal tissue expression of PSMA is negative to low. CTT’s small molecule drugs are unique as they bind irreversibly to the PSMA target and are rapidly internalized by PSMA-expressing tumor cells. As a consequence of this, more of the drug reaches and stays at the tumor site. CTT’s targeting agents act as a platform to effectively and safely deliver a wide variety of diagnostic and therapeutic payloads.
Appiture Biotechnologies, Inc
Currently, diagnosing autism spectrum disorder (ASD) is highly reliant on behavioral screening tools which can often introduce subjectivity into the screening procedure. Inconsistency in tool use and the introduction of bias through subjective assessment limit the ability of doctors to get an accurate picture of ASD risk. To date, no objective first-line ASD screening tool exists for use by doctors.
Our vision at Appiture Biotechnologies is a future more reliant on physical indicators of ASD risk. Through the integration of technology and medicine, we are developing technology to help doctors screen for ASD using an objective physical biomarker in the context of other developmental indicators of overall health.
Crimson Medical Solutions
Crimson Medical Solutions was founded in 2019 with the goal of creating innovative products for nurses. Each founder had personal connections with nurses and understood that they are often overworked and underserved by recent medical device innovations. We develop products by working directly with nurses to understand their workflows, struggles, and healthcare philosophy to create low-cost solutions that work.
Protein nanoparticles targeting inflammatory neutrophils in sepsis and inflammatory disease.
Matrix Diagnostics Biosystems (MxDx)
Develop decellularized matrices for patient-based cancer drug discovery and drug validation.
Raw Molecular Systems LLC (RMS)
RAW Molecular Systems LLC is a Spokane-based company that aims to challenge established thinking and give clients a unique advantage.
SOLUTIONS THAT SUIT YOU
We work collaboratively with our clients to uncover the most effective and efficient way to achieve their needs.
At RAW Molecular Systems LLC, we believe there is a better way to meet our clients’ needs. We’re a company that exists to help you achieve more than you ever thought possible.
Understanding all the unique touch-points of each client is essential to our business. We focus on building reliable connections, amazing results, and trusted experiences that are as useful as they are memorable.
Let’s do great things together. We can’t wait to work with you.
Chemosense Therapeutics LLC
A novel treatment for re-sensitization of resistant tumors to chemotherapy.
Utilizing mealworms as a means of degrading Styrofoam in a controlled and environmentally friendly manner.
Make sustainable farming cool andprofitable for the next generation of African farmers by creating access to farm support services, efficient production systems, and access to profitable market.
We believe in an Africa that feeds itself and the world sustainably—where economically sustainable food and farming system provide profit and resiliency.